pla~m,--; conCt-mrClwn oj fret bi(lJugically aCi.iv~ th~'r(lid hormone (.~--;1. In addition. the liver l~ the principal or~an re5p(ll1:;ible lor the com'er;;ion of thnoxine or T4 (a prohormone secreted b\· the thvroid <Tiand, to uiio-
doth~'ronil1t· or T3 (3"j.:i' -triiodothyronine), the biologi· cally active form of thyroid hormone at the level of the tissues (2, 3, 81. M051 tis5ues can convert T4 to either blO1ogicall~ active T3 or inert rT3 (3,3'.5' -triiodm:hyro· nine), however the liver i5 the principal site of T3 pro· duction and account" for grealer than 80C.:; of the T3 produced daily from T4 (2, chronic liver disea5e. a reduction in plasma T3 levels and an increase in rT:3 lewIs occurring in association with a normal T4 Je'>el and in the \'irtual absente of any clinical e,'jdence for hypothyroidism ha~ been noted (4. 8-lfd. Thi~ condition ha~ beer: identified as the low T;~ s~·n dr(lme h5-bi(lchi:'nileal (umponent~ (T:: and rT': le\el~ j haw been used to folio\\" the clinical response to medical therapy of alcuholico with liver disease and to predict the short-term sun'j\'al of patients with ad\'anced chronic liver disea5E' (];3-15).
Until recently, obtaining such data in patient5 with ad\"anced liver disease has been valuable only in a nega· tive sense in that it accurately predicted the patient's demise regardless of the efforts of his physicians to prevent such an outcome. \'·ith the recent development of orthotopic hepatic transplantation as a clinically use· ful therapy. the selection of appropriate patient~ for its application has become an issue of considerable concern to physicians. surgeons. government and the public 06-E-li. Because we are in a unique position to offer such heroic therapy to patient" with advanced irre\'er~ible liYer disease. we prospecti\'ely evaluated. in a double· blind fashion, the usefulness of obtaining rneasure~ of 86:2 . . Vol. 5, No.5, 198 ,S  THYROID HORMONES AND TRANSPLANTATION   86,) lilyroid hormone homeostasis in patients being considered for this procedure (16, :20) .
MATERIALS AND METHODS

PATIENTS
All 134 adult patients being considered for orthotopic liver transplantation from March, 1981 through December, 1983 at the Presbyterian-University Hospital, Pittsburgh, Pa. had on admission to hospital for their initial evaluation, blood obtained after an overnight fast plasma levels of T4, T3, rT3 and thyroid-stimulating hormone (TSH). The subsequent evaluation for and application of orthotopic liver transplantation to these patients proceeded without knowledge of these results and was based primarily upon the clinical experience of the involved physicians.
HORMONE ASSAYS Serum TSH was determined by specific radioimmunoassay using a kit obtained from Pharmacia Fine Chemicals (Piscataway, NJ). The detection limit of the assay was l.0 !l U per ml. The intraassay variation was less than 5%, and the interassay variation was less than 8%. Serum T3 was determined by a specific radioimmunoassay using a kit obtained from Corning Medical Diagnostics, Inc. (Medfield, Mass.). The interassay variation was less than 7%, and the intraassay variation was less than 3%. Serum T3 was determined also by a specific radioimmunoassay using a kit obtained from Corning Medical Diagnostics, Inc. The interassay variation for this unit was 10%, and its intraassay variation was less than 5%. Serum rT3 was determined using a specific radioimmunoassay kit obtained from Serono (Braintree, Mass.). The interassay variation for this kit was 11%, and its intraassay variation was less than 5%. Normal values for each hormone assayed were determined using blood obtained from 100 consecutive normal volunteer blood donors.
ANALYSIS
After closing the study on Decell?-ber 31, 1983, the values for each hormone obtained at the time of initial evaluation for possible liver transplantation were collected and segregated into two groups as follows: Group I-those who died waiting to be transplanted (n = 42; 21 men and 21 women) and Group II-those who underwent the procedure (n = 92). This latter group was later subdivided into those who died in hospital following transplantation (n = 27; 12 men and 15 women) and those who survived, and were discharged home (n = 65; 27 men and 38 women).
The mean values and the standard errors for each hormone assayed were determined for the entire group of patients studied and for each subgroup of patients identified above.
Statistical analysis was performed using the Student's t test. A p value less than 0.05 was considered to be significant.
Because the collected data were cross-sectional in nature, associations were assessed using the odds ratio as an approximation to the relative risk. In this setting, thvroid status was considered to be antecedent to the ou"tcome (death), thus permitting the odds ratio to be used as a measure of risk of experiencing the outcome when the antecedent factor was present compared to when the antecedent factor was absent. The odds ratio is not only an approximation to the relative risk, but the use of the logistic model gives rise to the odds ratio as a measure of association as welL Using the logarithm (to the base e) of the calculated odds ratio and constructing a confidence interval (Cn using the standard error of the log-odds ratio, permits one to observe whether or not the confidence interval of the odds ratio excludes unity [an odds ratio of unity (equal to one) indicates no excess risk]. WhEm the calculated odds ratio confidence interval excludes unity, a x 2 test is performed. While the x 2 itself is not useful as a measure of the degree of an association, the x 2 is an excellent measure of the significance of an association (21) . Table 1 is a listing of the patients studied and identified on the basis of their disease condition for which they were being considered as possible or actual candidates for liver transplantation. The mean values for TSH, T4, T3 and rT3 for the entire group of patients studied are shown in Table 2 . In Table 3 is shown an estimate of the degree of saturation of the thyroid-binding globulin and the frequency of various types of autoantibodies present· (29) 1 (6) 9 (22) • Number in parentheses = o/c. of total group who were positive for antibody.
RESULTS
'p < 0.01 compared to both primar~ biliary cirrhosis or primary sclerosing cholangitis groups.
in the patients compnsmg the three largest etiologic types of liver disease present in the populations studied.
No difference in TSH levels was noted between the various subgroups of patients studied. In contrast, T4, T3, rT3 levels and the ratios of T3/T4 and rT3/T3 clearly distinguished between the various subgroups of patienti' studied and defmed according to their outcome.
In Figure 1 io shown the T4 levels for the three subgroupi' of paTients STudied. A'i'. can be seen from the figurt' , nCI differencE:' in T4 levels .was noted between tho!'-E' who died waiTing to be transplanted and those who diE-cl ioll\lwi!1~ 1 hE-DT()L'edun, In contrast. however. those Wh(l ;;.unived had "greater T4 lewis (p < 0. (1) 
25.319).
The ratio of T3/T 4 levels in the patient s studied were even more clearl~' distinguished between the various subgroups (FiguTe 3). A'E wa::. the case for the individual hormone measurements, no differenCE-in thi~ ratio was noted between those who died waiting to have the procedure and those who died postoperati\'el~·. In contrast, those who survived had lower levels (p < 0.011. However, The ratio of rT3/T3 even more clearly distinguished between the three subgroups and identified those patients who would nOl survive to have the procedure performed within the time frame of the time required for the transplantation evaluation and donor identification and matching processes ( Figure 5J . Interestingly, those whcl died postoperatively had the lowest ratio::.
DISCUSSlO1\
The results of the present study confirm the work of previous investigators who haw suggested that the len'ls of thyroid hormone measured in blood can be used prognostically in patients with advanced liver diseas€' (12-15J. Specifically, those patients who were to die prior to being tramplanted had greater rT3 levels and greater rT;:;.'T:3 ratio;:. than did those who were to survive to have ,he procedure.
More importantly, the present data demonstrate sonw .. what paradoxically that those patients who will live long enough to be evaluated. matched with a donor and survive the procedure. have greater T4 and lower T3 levels and therefore a mueh smaller T~\iT4 ratio than dc. those who will die whether their death~ occur before OT after the procedure can be performed, The reasons responsiblE' for these findin?>' are unclear. In facl. one mighl ha\'e exppcted the converse: that is. those with the more se\'en livpl disf<1~e and presumab]\ therefore the pooreST ;'U!> vival rates would be expected to have the lowest T3 level::;, not greater levels. As shown in Table 2 , as a group, the patients with liver disease had higher TSH levels than did the normal controls, albeit levels still well within the normal range. Whether this reflects some minor degree of thyroid dysfunction associated with the liver diseases studied and accounts, at least in part, for the findings seems likely.
These data raise interesting questions about how a decision should be made about who should be afforded a liver transplant from among a list of potential recipientsonce an acceptable donor organ has been identified. Should those patients with the lower. T4 levels and greater T3 levels be bypassed in favor of those with greater T4 levels and lower T3 levels who would appear to have a better chance for survival'? Even more difficult is the question: Should those patients with very high rT3 levels be eliminated from all further consideration because of their very poor chance of survival'? Conversely, should those with very high rT3 levels be the ones we preferentially select once they are identified for immediate transplantation because of their very poor prognosis'? Obviously, the present data do not allow us to make any such recommendations. However, should our findings be replicated by other groups performing liver transplantation, considerable thought will have to be given to obtaining answers for these rather weighty questions.
Similarly, although not a part of the present study, one has to wonder if following T3 and rT3 levels during the postoperative period would help to identify those patients who are having rejection problems and/or rejection-associated enhanced immunosuppression which can lead to the development of an opportunistic infection which is the major cause of death one or more weeks following successful transplantation.
Obviously, much more remains to be learned about liver transplantation, the selection process and -when such surgery should be offered to acceptable candidates for the procedure. The present study, however, i~ a beginning. The use of laboratory tests which are easily performed using radioimmunoassay kits, widely available, highly reproducible and having a rapid turn around time such as T4, T3 and rT3 would appear to be a reasonable first step toward improving and fine tuning our decision-making processes relative to the application of such heroic surgery.
